Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
Mora
C
C
Nephrology Service and Research Unit, Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Macía
M L
ML
García
J
J
Navarro
J F
JF
D000368:Aged; D045930:Anabolic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D001161:Arteriosclerosis / Q000503:physiopathology; D006801:Humans; D008055:Lipids / Q000009:adverse effects / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077603:Nandrolone Decanoate; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011446:Prospective Studies; D051437:Renal Insufficiency / Q000150:complications / Q000628:therapy
D045930:Anabolic Agents; D008055:Lipids; D009277:Nandrolone; D000077603:Nandrolone Decanoate